Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients

被引:29
|
作者
Lang, H
Schlitt, HJ
Schmidt, H
Flemming, P
Nashan, B
Scheumann, GFW
Oldhafer, KJ
Manns, MP
Raab, R
机构
[1] Univ Essen Gesamthsch Klinikum, Klin & Poliklin Allgemein & Transplantat Chirurg, D-45122 Essen, Germany
[2] Med Hsch Hannover, Abdominal & Transplantat Chirurg Klin, D-30625 Hannover, Germany
[3] Med Hsch Hannover, Gastroenterol & Hepatol Abt, D-30625 Hannover, Germany
[4] Med Hsch Hannover, Abt Pathol, D-30625 Hannover, Germany
关键词
liver transplantation; neuroendocrine pancreatic tumors; hepatic metastases;
D O I
10.1007/s004230050216
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Metastatic neuroendocrine pancreatic tumors have a poor prognosis. We have studied retrospectively the efficacy of liver transplantation as ultimate therapy of otherwise untreatable symptomatic neuroendocrine hepatic metastases originating in the pancreas. Methods: We reviewed our experience of liver transplantation (LTx) for hepatic metastases of neuroendocrine pancreatic tumors in ten patients. The indication for liver grafting was seen in cases of irresectable metastases and when patients were suffering from otherwise untreatable tumor-associated symptoms due to massive hormonal release or large intra-abdominal turner bulk. Results: In four patients, the primary tumors had been removed before LTx, in five patients simultaneously with LTx and in one case 46 months after grafting. There was no operative mortality. After hepatectomy and LTx, all patients had complete relief of symptoms and all preoperatively increased hormonal levels returned to normal. In nine of ten patients, the transplant procedure had the potential for cure, whereas, in one patient, the primary tumor had remained in situ at LTx and was removed 46 months later by an R2-resection. At present, nine patients are alive with a median follow-up of 33 months (range 13.5 months to 117 months). The one patient in whom the primary tumor was removed after transplantation died due to massive intra-abdominal tumor spread 68 months after LTx. Currently, two patients are without evidence of disease, but one of them after re-operation because of lymph-node metastases 8 months after transplantation. The longest disease-free survival is now more than 7 years. In seven of nine patients, tumor recurred between 1.5 months and 48 months after transplantation. Conclusions: Patients with otherwise untreatable symptomatic neuroendocrine hepatic metastases of pancreatic origin may benefit from total hepatectomy and liver transplantation with regard to symptomatic relief and long-term survival, despite frequent recurrence of disease. In some patients, liver transplantation may even offer the chance for cure.
引用
收藏
页码:370 / 377
页数:8
相关论文
共 50 条
  • [21] Different patterns of recurrence after liver resection and transplantation for metastatic neuroendocrine tumors. Single center ecperience
    Coppa, J.
    Rossi, R. E.
    Bongini, M.
    Maspero, M.
    Sposito, C.
    Pusceddu, S.
    Corti, F.
    Busset, Droz Dit M.
    Maccauro, M.
    Mazzaferro, V
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 : 193 - 193
  • [22] Surgical Treatment of Metastatic Tumors to the Pancreas: A Single Center Experience and Review of the Literature
    Stefano Crippa
    Carlo Angelini
    Chiara Mussi
    Claudia Bonardi
    Fabrizio Romano
    Paola Sartori
    Franco Uggeri
    Giorgio Bovo
    World Journal of Surgery, 2006, 30
  • [23] Surgical treatment of metastatic tumors to the pancreas: A single center experience and review of the literature
    Crippa, Stefano
    Angelini, Carlo
    Mussi, Chiara
    Bonardi, Claudia
    Romano, Fabrizio
    Sartori, Paola
    Uggeri, Franco
    Bovo, Giorgio
    WORLD JOURNAL OF SURGERY, 2006, 30 (08) : 1536 - 1542
  • [24] Cystic Neuroendocrine Tumors of the Pancreas (c-pNETs): A Single-Center Experience
    Coakley, M.
    Kommineni, V
    Pannala, R.
    Chen, L.
    Zhang, J.
    Wasif, N.
    Halfdanarson, T.
    NEUROENDOCRINOLOGY, 2016, 103 : 108 - 108
  • [25] Cystic Neuroendocrine Tumors of the Pancreas (c-pNETs): A Single-Center Experience
    Kommineni, Vishnu
    Coakley, Maria F.
    Pannala, Rahul
    Chen, Longwen
    Zhang, Jun
    Wasif, Nabil
    Halfdanarson, Thorvardur R.
    PANCREAS, 2016, 45 (03) : 477 - 477
  • [26] Donor Hepatectomy for Living Related Liver Transplantation: Single-Center Experience
    Sozen, Hakan
    Ozen, Onur
    Yagci, Gokhan
    Dalgic, Aydin
    TRANSPLANTATION, 2016, 100 : S231 - S231
  • [27] GASTRIC NEUROENDOCRINE TUMORS: A SINGLE CENTER EXPERIENCE
    Ioannis, Pilpilidis
    Dimitrios, Tzilves
    Kostas, Soufleris
    Georgia, Lazaraki
    Persefoni, Xiroy
    Kostas, Skordas
    Anestis, Tarpagos
    ANNALS OF ONCOLOGY, 2014, 25
  • [28] Neuroendocrine tumors:: A single-center experience
    Özdemir, NY
    Öksüzoglu, B
    Budakoglu, B
    Abali, H
    Zengin, N
    NEUROENDOCRINOLOGY, 2006, 83 (01) : 41 - 41
  • [29] Neuroendocrine tumors (NETs) - experience of a single Center
    Sincu, Mihaela Cornelia
    Cocuz, Iuliu Gabriel
    Tinca, Andreea Catalina
    Niculescu, Raluca
    Sabau, Adrian-Horatiu
    Chiorean, Diana Maria
    Morariu, Silviu Horia
    Cotoi, Ovidiu Simion
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2021, 62 (02): : 457 - 463
  • [30] In vivo total or partial hepatectomy followed by ex vivo liver resection and autotransplantation for malignant tumors: a single center experience
    Xu, Shaoyan
    Hu, Chenlu
    Jiang, Zedong
    Li, Guogang
    Zhou, Bo
    Gao, Zhenzhen
    Yan, Sheng
    FRONTIERS IN ONCOLOGY, 2023, 13